Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.70
$2.3412.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.20B | 1.18B | 1.15B | 1.10B | 1.06B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20B | 1.18B | 1.15B | 1.10B | 1.06B |
| Cost of Revenue | 444.94M | 451.55M | 452.11M | 437.37M | 425.90M |
| Gross Profit | 753.13M | 730.48M | 697.66M | 664.74M | 636.94M |
| SG&A Expenses | 317.06M | 317.78M | 314.28M | 306.22M | 300.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 896.61M | 901.80M | 894.98M | 867.82M | 847.36M |
| Operating Income | 301.46M | 280.22M | 254.79M | 234.28M | 215.48M |
| Income Before Tax | 297.47M | 242.33M | 183.38M | 162.82M | 143.85M |
| Income Tax Expenses | 74.57M | 75.26M | 74.82M | 68.63M | 62.83M |
| Earnings from Continuing Operations | 222.90 | 167.07 | 108.57 | 94.19 | 81.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 222.90M | 167.07M | 108.57M | 94.19M | 81.02M |
| EBIT | 301.46M | 280.22M | 254.79M | 234.28M | 215.48M |
| EBITDA | 368.52M | 345.55M | 317.57M | 293.30M | 271.24M |
| EPS Basic | 0.38 | 0.29 | 0.19 | 0.16 | 0.14 |
| Normalized Basic EPS | 0.32 | 0.29 | 0.26 | 0.24 | 0.22 |
| EPS Diluted | 0.38 | 0.28 | 0.18 | 0.16 | 0.14 |
| Normalized Diluted EPS | 0.31 | 0.29 | 0.26 | 0.24 | 0.22 |
| Average Basic Shares Outstanding | 2.34B | 2.34B | 2.34B | 2.33B | 2.33B |
| Average Diluted Shares Outstanding | 2.36B | 2.36B | 2.35B | 2.35B | 2.34B |
| Dividend Per Share | 0.25 | 0.26 | 0.26 | 0.25 | 0.25 |
| Payout Ratio | 44.64% | 52.76% | 69.51% | 78.34% | 89.85% |